Identity
High-performance liquid chromatography confirms each ingredient is what the label says it is.
Lab testing & quality
Quality is a process, not a slogan. This page explains how CardioC2 is made and tested. The results for the current run live on the verification page.
CardioC2 is manufactured in the United States in a facility that is FDA-registered and operates under current Good Manufacturing Practices (cGMP). That framework governs everything from raw-material handling to cleaning, documentation and finished-product release, with records kept for every batch.
Finished-product testing is performed by Halverson Bioanalytics, LLC, an independent, third-party laboratory accredited to ISO/IEC 17025, the international standard for testing competence. Using an outside lab matters: the people checking the product have no incentive to look the other way.
High-performance liquid chromatography confirms each ingredient is what the label says it is.
Active levels are quantified by UHPLC-PDA so each serving delivers the dose on the panel.
ICP-MS screening for lead, arsenic, cadmium and mercury, with this batch testing < 0.2 ppm (ICP-MS).
Total plate count, yeast, mold and pathogen screening. This batch result: Pass - within USP limits.
Screened to confirm residues fall within accepted safety limits.
Final check that the finished bottle matches the approved specification.
Each ingredient arrives with its own documentation and is tested on intake before it ever enters a batch. After blending and encapsulation, the finished product is tested again and held until it passes. Only then is it released, assigned a batch code and made available through this portal. The current cycle, Q2 2026, is documented under batch CC2-26Q2-0517 and Certificate of Analysis HB-COA-26-7741.
CardioC2 is non-GMO and made without gluten or artificial colors. It is produced in a facility that also handles common allergens, so anyone with a severe allergy should review the label and contact us first. The product is formulated for healthy adults.